135 related articles for article (PubMed ID: 7698169)
1. Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
Baker AJ; Palmer J; Johnson M; Fuller RW
Eur J Pharmacol; 1994 Nov; 264(3):301-6. PubMed ID: 7698169
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
4. Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro.
Baker AJ; Fuller RW
J Leukoc Biol; 1995 Mar; 57(3):395-400. PubMed ID: 7884310
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.
Cook SJ; Small RC; Berry JL; Chiu P; Downing SJ; Foster RW
Br J Pharmacol; 1993 Aug; 109(4):1140-8. PubMed ID: 8104643
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
McCrea KE; Hill SJ
Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells.
Mohede IC; Van Ark I; Brons FM; Van Oosterhout AJ; Nijkamp FP
Int J Immunopharmacol; 1996 Mar; 18(3):193-201. PubMed ID: 8796447
[TBL] [Abstract][Full Text] [Related]
9. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
Whelan CJ; Johnson M
Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536
[TBL] [Abstract][Full Text] [Related]
11. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.
Kanthakumar K; Cundell DR; Johnson M; Wills PJ; Taylor GW; Cole PJ; Wilson R
Br J Pharmacol; 1994 Jun; 112(2):493-8. PubMed ID: 7915610
[TBL] [Abstract][Full Text] [Related]
12. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
January B; Seibold A; Allal C; Whaley BS; Knoll BJ; Moore RH; Dickey BF; Barber R; Clark RB
Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
Butchers PR; Vardey CJ; Johnson M
Br J Pharmacol; 1991 Nov; 104(3):672-6. PubMed ID: 1724629
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro.
Anderson R; Feldman C; Theron AJ; Ramafi G; Cole PJ; Wilson R
Br J Pharmacol; 1996 Apr; 117(7):1387-94. PubMed ID: 8730730
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Grove A; Lipworth BJ
Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
[TBL] [Abstract][Full Text] [Related]
17. Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.
Bergendal A; Lindén A; Skoogh BE; Gerspacher M; Anderson GP; Löfdahl CG
Br J Pharmacol; 1996 Mar; 117(6):1009-15. PubMed ID: 8882590
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology of salmeterol.
Johnson M; Butchers PR; Coleman RA; Nials AT; Strong P; Sumner MJ; Vardey CJ; Whelan CJ
Life Sci; 1993; 52(26):2131-43. PubMed ID: 8099695
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
20. Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
Nials AT; Sumner MJ; Johnson M; Coleman RA
Br J Pharmacol; 1993 Feb; 108(2):507-15. PubMed ID: 8095419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
